Ufp Technologies (UFPT) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.67% |
| Dec 31, 2025 | -3.48% |
| Sep 30, 2025 | 0.89% |
| Jun 30, 2025 | 3.96% |
| Mar 31, 2025 | 13.85% |
| Dec 31, 2024 | 29.15% |
| Sep 30, 2024 | 7.51% |
| Jun 30, 2024 | 26.17% |
| Mar 31, 2024 | 35.46% |
| Sep 30, 2023 | 4.62% |
| Jun 30, 2023 | -2.21% |
| Mar 31, 2023 | -1.64% |
| Dec 31, 2022 | -34.87% |
| Sep 30, 2022 | -23.22% |
| Jun 30, 2022 | -30.55% |
| Mar 31, 2022 | -35.90% |
| Sep 30, 2021 | 1.90% |
| Jun 30, 2021 | 2.31% |
| Mar 31, 2021 | -0.06% |
| Dec 31, 2020 | -4.05% |
| Sep 30, 2020 | -9.90% |
| Jun 30, 2020 | -15.91% |
| Mar 31, 2020 | -21.36% |
| Dec 31, 2019 | -35.70% |
| Sep 30, 2019 | -19.19% |
| Jun 30, 2019 | -30.37% |
| Mar 31, 2019 | -40.91% |
| Dec 31, 2018 | -38.67% |
| Sep 30, 2018 | -33.19% |
| Jun 30, 2018 | -29.63% |
| Mar 31, 2018 | -26.05% |
| Dec 31, 2017 | 2.55% |
| Sep 30, 2017 | 3.64% |
| Jun 30, 2017 | 3.37% |
| Mar 31, 2017 | 4.10% |
| Dec 31, 2016 | 0.99% |
| Sep 30, 2016 | 0.98% |
| Jun 30, 2016 | 0.55% |
| Mar 31, 2016 | 1.94% |
| Dec 31, 2015 | 6.16% |
| Sep 30, 2015 | 5.58% |
| Jun 30, 2015 | 8.68% |